These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6818151)

  • 21. Pathogenesis of pulmonary tuberculosis.
    Dannenberg AM
    Am Rev Respir Dis; 1982 Mar; 125(3 Pt 2):25-9. PubMed ID: 6803630
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.
    Hamasur B; Haile M; Pawlowski A; Schröder U; Williams A; Hatch G; Hall G; Marsh P; Källenius G; Svenson SB
    Vaccine; 2003 Sep; 21(25-26):4081-93. PubMed ID: 12922145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of the delayed-type hypersensitivity response in tuberculous guinea pigs and mice tested with several mycobacterial antigen preparations.
    Collins FM
    Am Rev Respir Dis; 1983 May; 127(5):599-604. PubMed ID: 6221679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The formation of the granuloma in tuberculosis infection.
    Orme IM; Basaraba RJ
    Semin Immunol; 2014 Dec; 26(6):601-9. PubMed ID: 25453231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice.
    Wieland CW; Florquin S; Chan ED; Leemans JC; Weijer S; Verbon A; Fantuzzi G; van der Poll T
    Int Immunol; 2005 Nov; 17(11):1399-408. PubMed ID: 16141243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy.
    John M; French MA
    Med J Aust; 1998 Nov; 169(9):473-4. PubMed ID: 9847899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological evaluation of a novel Mycobacterium tuberculosis antigen, Rv3117, absent in Mycobacterium bovis BCG.
    Zhao J; Sun Z; Pei H; Ye J; Chen C; Samten B; Zhang S; Guo X
    Mol Med Rep; 2013 Nov; 8(5):1587-93. PubMed ID: 24045507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: Experimental tuberculous cavities].
    Tsuyuguchi I
    Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1710-2. PubMed ID: 12170731
    [No Abstract]   [Full Text] [Related]  

  • 29. Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs.
    Youmans GP; Youmans AS
    J Bacteriol; 1969 Jan; 97(1):134-9. PubMed ID: 4236903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculin shock in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):273-79. PubMed ID: 823795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis immunity and allergy].
    Kekkaku; 1968 Mar; 43(3):25-8. PubMed ID: 4971117
    [No Abstract]   [Full Text] [Related]  

  • 32. Tuberculin reaction in children treated with isoniazid.
    Hsu KH
    Am J Dis Child; 1983 Nov; 137(11):1090-2. PubMed ID: 6416056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
    Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
    Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis?
    Hernandez-Pando R; Orozco H; Honour J; Silva P; Leyva R; Rook GA
    FEMS Immunol Med Microbiol; 1995 Sep; 12(1):63-72. PubMed ID: 8580904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of cell-mediated immunity to Mycobacterium leprae in mice.
    Patel PJ; Lefford MJ
    Infect Immun; 1978 Jan; 19(1):87-93. PubMed ID: 415009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to purified tuberculin (PPD) in pulmonary tuberculosis & their correlation with PPD skin sensitivity.
    Gupta AK; Jamil Z; Srivastava VK; Tandon A; Saxena KC
    Indian J Med Res; 1983 Oct; 78():484-8. PubMed ID: 6421727
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary demonstration of human tuberculoimmunity in vitro.
    Crowle AJ; May M
    Infect Immun; 1981 Jan; 31(1):453-64. PubMed ID: 7012004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of delayed-type hypersensitivity in the immunity against tuberculous infection].
    Kalmykova GH
    Probl Tuberk; 1973; 51(1):57-63. PubMed ID: 4199377
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide.
    Yamamura Y; Ogawa Y; Maeda H; Yamamura Y
    Am Rev Respir Dis; 1974 Jun; 109(6):594-601. PubMed ID: 4209492
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunol Today; 1991 Jul; 12(7):228-33. PubMed ID: 1822092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.